国产精品一区二区av麻豆,国产成人综合色视频精品,亚洲伊人成综合网2222,国产凸凹视频一区二区

抗細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體(異硫氰酸熒光素標(biāo)記)

FITC-Linked Anti-Programmed Cell Death Protein 1 (PD1) Monoclonal Antibody

CD279; PDCD1; SLEB2; HPD1P

  • 抗細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體(異硫氰酸熒光素標(biāo)記)產(chǎn)品包裝(模擬)
  • 抗細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體(異硫氰酸熒光素標(biāo)記)產(chǎn)品包裝(模擬)
  • Certificate通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

用法

免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學(xué)：5-20μg/mL;1:50-200
免疫細(xì)胞化學(xué)：5-20μg/mL;1:50-200
最佳稀釋倍數(shù)最終由用戶(hù)決定。

儲(chǔ)存

Store at 4°C, protected from prolonged exposure to light.

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào)適用物種：Homo sapiens (Human，人)應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA751Hu02細(xì)胞程序性死亡蛋白1(PD1)活性蛋白Cell?culture;?Activity?Assays.
APA751Hu01細(xì)胞程序性死亡蛋白1(PD1)活性蛋白Cell?culture;?Activity?Assays.
RPA751Hu01細(xì)胞程序性死亡蛋白1(PD1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPA751Hu61細(xì)胞程序性死亡蛋白1(PD1)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA751Hu61細(xì)胞程序性死亡蛋白1(PD1)活性蛋白Cell?culture;?Activity?Assays.
RPA751Hu02細(xì)胞程序性死亡蛋白1(PD1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA751Hu02細(xì)胞程序性死亡蛋白1(PD1)多克隆抗體WB; IHC; ICC; IP.
PAA751Hu01細(xì)胞程序性死亡蛋白1(PD1)多克隆抗體WB; IHC; ICC/IF
RAA751Hu23細(xì)胞程序性死亡蛋白1(PD1)重組抗體WB; IF; ICC; IHC; IP; FCM.
MAA751Hu24細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB
MAA751Hu25細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB; IHC; ICC; IP.
RAA751Hu01細(xì)胞程序性死亡蛋白1(PD1)重組抗體ICC/IF
MAA751Hu27細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB; IHC; ICC; IP.
MAA751Hu21細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB
MAA751Hu29細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB; IHC; ICC; IP.
RAA751Hu22細(xì)胞程序性死亡蛋白1(PD1)重組抗體WB; IF; ICC; IHC; IP; FCM.
MAA751Hu23細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB
MAA751Hu22細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體WB; IHC; ICC; IP.
FAA751Hu86抗細(xì)胞程序性死亡蛋白1(PD1)單克隆抗體(異硫氰酸熒光素標(biāo)記)Flow cytometry.
SEA751Hu細(xì)胞程序性死亡蛋白1(PD1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA751Hu細(xì)胞程序性死亡蛋白1(PD1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSA751Hu01細(xì)胞程序性死亡蛋白1(PD1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
OncotargetCirculating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.[pubmed:28545019]
CyberLeninkaПотенциальные биомаркеры эффективности терапии ниволумабом при метастатическом почечно-клеточном раке[:]
АНАЛИЗ РЕЗУЛЬТАТОВ ЛЕЧЕНИЯ БОЛЬНЫХ МЕТАСТАТИЧЕСКИМ РАКОМ ПОЧКИ, ПОЛУЧАВШИХ АНТИ-PD-1?ТЕРАПИЮ В РАМКАХ ПРОГРАММЫ?…[]
International Journal of Molecular?SciencesDesign and Synthesis of A PD-1 Binding Peptide and Evaluation of Its Anti-Tumor Activity[Pubmed: 30699956]
PLoS?OneClinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated?…[Pubmed: 30807610]
CancersPredictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study[Pubmed: 32085544]